Mediwound announces the appointment of hani luxenburg as chief financial officer

Yavne, israel, march 16, 2023 (globe newswire) -- mediwound ltd. (nasdaq: mdwd), a fully integrated biopharmaceutical company specializing in next-generation biotherapeutic solutions for tissue repair and regeneration, is pleased to announce the appointment of ms. hani luxenburg as its new chief financial officer, effective may 14, 2023. ms. luxenburg will replace mr. boaz gur-lavie, who has served as mediwound's chief financial officer for the past four years. mr. gur-lavie will remain with the company through july 31, 2023 to ensure an orderly transition.
MDWD Ratings Summary
MDWD Quant Ranking